I am a
Home I AM A Search Login

Neuropathic Pain (NeuPSIG)


Share this

NeuPSIG LEADERSHIP

Executive Committee 

  • Chair:
    Theodore Price
    United States
  • Past Chair:
    Patrick Dougherty
    United States
  • Vice Chair:
    David Bennett
    United Kingdom
  • Treasurer:
    Franziska Denk
    United Kingdom
  • Secretary:
    Margarita Calvo
    Chile
  • Early Career Researcher Officer:
    Pascal Roderer
    Germany

Management Committee Members 

  • Lesley Colvin
    United Kingdom
  • Muhammad Saad
    United States
  • Jan Vollert
    United Kingdom
  • Julia Forstenpointner
    Germany
  • Pall Karlsson
    Denmark
  • Suellen Walker
    United Kingdom

Honorary Members

  • Blair H Smith
    University of Dundee, UK
     
  • Raja N Srinivasa
    Johns Hopkins University, USA
     
  • Rolf-Detlef Treede
    Germany
     
  • Jonathan Dostrovsky
    Canada
     
  • Robert H. Dworkin
    USA
  • Troels Jensen
    Denmark 
  • Chris Wells
    UK
     
  • Turo Nurmikko
    UK
     
  • Edmond Charlton
    UK

CONTACT NeuPSIG

What is Neuropathic Pain?

Neuropathic pain is a chronic pain condition caused by damage to the somatosensory nervous system, leading to abnormal pain signals. 

Approximately 7-10% of the general population are affected, with prevalence increasing with age and certain medical conditions such as diabetes and post-herpetic neuralgia. 

However, neuropathic pain is still inadequately treated, thus highlighting the urgent need for continued research and the development of more effective therapies. 

NeuPSIG Mission and Vision

NeuPSIG’s mission is to advance the understanding of neuropathic pain mechanisms, assessment, prevention, and treatment, and to disseminate this knowledge to our global community of members and partners.

Mission_Vision

The NeuPSIG vision is to:

  • Strive to be the main global community for neuropathic pain researchers, clinicians, and people with neuropathic pain.
  • Educate our members, other clinicians, scientists and the public on neuropathic pain. We will do so via The International Congress on Neuropathic Pain, via workshops, symposia and satellite meetings at the IASP World Congress on Pain, via additional international and local meetings, and via the IASP website and other online activities.
  • Foster collaboration between basic and clinical researchers on neuropathic pain, with a particular focus on early career professionals, to support the education and professional development of future leaders in this field.
  • Synthesize and disseminate the latest state-of-the art information about assessment, treatment and prevention of neuropathic pain.
  • Work with the wider pain research community to address common challenges and improve best practices.

NeuPSIG Initiatives:

9th International Congress on Neuropathic Pain (NeuPSIG 2025) in Berlin, Germany

From 4 – 6 September 2025, NeuPSIG held the 9th International Congress on Neuropathic Pain (NeuPSIG 2025) in Berlin, Germany.

Revising Guidelines for Neuropathic Pain Assessment

In 2022-2023, NeuPSIG was instrumental in revising the guidelines for neuropathic pain assessment as part of a joint effort with the European Academy of Neurology and the European Pain Federation. This work has now been published.

NeuPSIG is currently working on another initiative to develop guidelines for investigating chemotherapy-induced pain (CIPN) in preclinical animal models and in the clinic. We are asking for volunteers for this essential work. Interested members can contact Dr. Lesley Colvin and read more about our plans here.

NeuPSIG and its members have led or taken part in many similar important initiatives in the past decade. Here are just a few select publications that have arisen from this:

NeuPSIG History:

NeuPSIG was founded in 1999 by Chris Wells and Ed Charlton. It is one of IASP's largest SIGs. Over the years, it has had a newsletter and its own website and runs a large biennial congress.

Neuropathic Pain Definition
In 1994, the IASP defined neuropathic pain as pain caused by a dysfunction or lesion in the nervous system. In 2008, NeuPSIG proposed a new definition that excluded the term "dysfunction". The IASP Taxonomy Committee accepted a slightly modified version of this definition. Read more >

Grading System Evaluation
As part of the 2015 Global Year Against Neuropathic Pain, NeuPSIG established a committee to critically evaluate the use of the grading system seven years after its publication, assess its usefulness and limitations, and update it if necessary for improved application in clinical and research settings. Read more >

NeuPSIG Members Nanna Finnerup and Nadine Attal
NeuPSIG Members Nanna Finnerup and Nadine Attal
Exhibitors at NeuPSIG 2023 in Lisbon
Exhibitors at NeuPSIG 2023 in Lisbon

NeuPSIG Meetings  

  • NeuPSIG Satellite Event at the IASP 2024 World Congress on Pain in Amsterdam. See the August 2024 newsletter.
  • 2023 NeuPSIG Congress in Lisbon 
    • 8 Plenary lectures/debates 
    • 24 Topical Workshops 
    • 253 Posters 
    • 2 Hands-on workshops (QST and Skin Biopsy) 
    • $35,000 allocated to bursaries for trainee/ECR attendance 
    • Trainee Reception 
  • 2019 NeuPSIG Congress in London 
  • 2015 Global Year Against Neuropathic Pain 

NeuPSIG Resources:

More Resources Coming Soon